Skip to main content
Caplight Logo









Werlabs

Werlabs

Private
StockholmHealthcare & Life Scienceshttps://werlabs.se/

Last Round

VC Round

Mar 1, 2023

Est. Valuation

$59.52M

Total Funding Raised

$4.23M

Company Overview

Werlabs is a Swedish health technology company that provides preventative health screening services through blood tests, blood pressure measurements, and health surveys.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Healthcare Analytics, Patient Engagement

Business Model

B2C

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

blood testingpreventive healthhealth checkupdirect-to-consumer lab testsbiomarker analysisdigital health journaltelemedicineemployee health benefitsprecision medicinehealth techlab testingbiohackinglongevity trackingclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Werlabs Comparables

Compare Werlabs with similar companies based on industry and business-model similarity.

Werlabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Svensk Provtagning AB
88%
Medisera Health
84%
Blodkollen Sverige AB
81%

Werlabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 1, 2023
VC RoundDec 22, 2018
Series AAug 11, 2016
SeedJul 14, 2015

Key People

Founding team and executive leadership

Henrik Forsberg

CEO

Executive Team

Simon Lindgren

Chief Technology Officer

Executive Team

Mehran Farshid

Fractional CFO

Executive Team

Maral Biniazan

Chief Product Officer

Executive Team

Werlabs Investors

Notable investors and investment history

Werlabs investors
InvestorRounds
Heartcore CapitalSeries A
Oscaria Capital ABSeries A
3T InvestSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2023

    $1.43M round raised

Werlabs Filings

Explore SEC and related filing metadata, where available.

Werlabs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Werlabs's valuation, stock price, and market status.

Is Werlabs a public or private company?

Werlabs is a private company.

What is the current stock price of Werlabs?

Werlabs is a private company with no public stock price. No recent secondary market data is available.

How much is Werlabs worth (valuation)?

Valuation information for Werlabs is not publicly available.

Can I buy Werlabs stock?

Werlabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Werlabs's last funding round?

Werlabs's most recent funding round was VC Round on December 21, 2018.

Who are the main investors in Werlabs?

Key investors in Werlabs include Heartcore Capital.

Will Werlabs IPO soon?

No public IPO plans have been announced for Werlabs.

How can I track Werlabs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Werlabs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersStockholm
Employee Range55
Year Founded2013
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?